Cooperative Agreement 2P2CMS332034
Award Date 8/1/25
Completion Date 12/31/35
Dollars Obligated $314K
Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Mississippi, USA
Similar Awards
- The Department of Social Services Connecticut was awarded a $7,404,199 Cooperative Agreement by the Centers for Medicare and Medicaid Services under the Cell and Gene Therapy (CGT) Access Model (CFDA 93.885) to increase access to cell and gene therapy for Medicaid members with sickle cell disease in Connecticut. Key activities include: Developing educational materials and raising awareness about cell and gene therapies through collaborations with a community-based organization and four...
- The Mississippi Division of Medicaid (DOM) was awarded a $17 million Cooperative Agreement under the Transforming Maternal Health (TMaH) Model (CFDA 93.869) from the Centers for Medicare and Medicaid Services (CMS). The 10-year project, spanning from January 1, 2025, to December 31, 2034, aims to enhance access to maternal care, improve maternal health quality and safety, and promote whole-person care through value-based payment incentives. Key initiatives include assessing the state's midwifery...
- The Illinois Department of Healthcare and Family Services (HFS) was awarded a $794,800 Cooperative Agreement under the Centers for Medicare and Medicaid Services' (CMS) Cell and Gene Therapy (CGT) Access Model (CFDA 93.885). The award will fund HFS staff to implement the CGT Access Model, conduct research to evaluate Medicaid customer access to sickle cell disease CGTs and the effectiveness of wraparound services, and support Community-Based Organizations (CBOs) to provide education,...
- The North Carolina Department of Health and Human Services (NC DHHS) was awarded a $558,941 cooperative agreement from the Centers for Medicare and Medicaid Services (CMS) under the Cell and Gene Therapy (CGT) Access Model program (CFDA 93.885). The funding will support a set of activities aimed at ensuring the successful implementation of the CGT Access Model in North Carolina, with the overarching goal of strengthening the state's capacity to provide access to cell and gene therapies for...
- The Pennsylvania Department of Human Services (DHS) was awarded a $794,800 Cooperative Agreement from the Centers for Medicare and Medicaid Services (CMS) under the federal Cell and Gene Therapy (CGT) Access Model program (CFDA 93.885). The funding will be used to provide additional services, education, and supports for Medicaid beneficiaries who may be candidates for sickle cell disease gene therapy. DHS will collaborate with the Pennsylvania Department of Health's Sickle Cell Disease...
- The Department of Health and Human Services Centers for Medicare and Medicaid Services awarded a $875,000 Block Grant to the Mississippi Division of Medicaid under the Medical Assistance Program (CFDA 93.778) for the period of October 1, 2021 through September 30, 2022. The Medical Assistance Program provides financial assistance to states for medical assistance payments on behalf of cash assistance recipients, children, pregnant women, and the aged who meet income and resource requirements....
- The Rhode Island Executive Office of Health and Human Services (EOHHS) was awarded a $793,419.04 Cooperative Agreement under the Centers for Medicare and Medicaid Services' (CMS) Cell and Gene Therapy (CGT) Access Model federal grant program (CFDA 93.885). The funding will be used to enhance access to cell and gene therapies and improve care for individuals with sickle cell disease in Rhode Island through a comprehensive, multi-faceted approach. Key activities include developing evidence-based...
- This $355,494 Formula Grant award from the U.S. Department of Health and Human Services Administration for Community Living (CFDA 93.071 - Medicare Enrollment Assistance Program) supports outreach, education, and application assistance for Medicare beneficiaries in Mississippi. Key services include conducting community outreach, providing one-on-one enrollment counseling, and helping beneficiaries apply for programs such as the Medicare Part D Low Income Subsidy and Medicare Savings Programs....
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $286,510 Cooperative Agreement under the Blood Disorder Program: Prevention, Surveillance, and Research (CFDA 93.080) to the Center for Public Health Innovation, a woman-owned non-profit organization, for the Sickle Cell Data Collection Program - 2023. This 5-year project, beginning on September 30, 2023, aims to work with state health agencies and other partners to plan, develop, implement, coordinate, and evaluate programs and...
- The Mississippi State Department of Health (MSDH) has been awarded a $3,461,808.00 Cooperative Agreement from the Centers for Disease Control and Prevention's (CDC) Immunization Cooperative Agreements (CFDA 93.268) program. This five-year agreement, effective July 1, 2025 through June 30, 2030, will enable MSDH to strengthen vaccine-preventable disease prevention and response efforts in Mississippi. Key objectives include increasing immunization rates among children, adolescents, and...